Ultragenyx Pharmaceutical Inc. buy Barclays PLC
Start price
24.11.25
/
50%
€28.40
Target price
24.11.26
€43.44
Performance (%)
-25.70%
Price
17.04.26
€20.66
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.70%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.873% | 4.873% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Barclays_PLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Barclays PLC from $81.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Barclays_PLC for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€45.20
06.08.24
06.08.24
€74.24
06.08.25
06.08.25
-48.67%
07.08.25
07.08.25
